Verastem, Inc. Available-for-sale Securities
Verastem, Inc. (VSTM) had Available-for-sale Securities of $8.99 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2017-11-07
- 2017-09-30: Available-for-sale Securities $8.99M.
- 2017-06-30: Available-for-sale Securities $30.34M.
- 2017-03-31: Available-for-sale Securities $44.39M.
- 2016-12-31: Available-for-sale Securities $48.55M.
| Period end | Available-for-sale Securities |
|---|---|
| 2017-09-30 | $8.99M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $30.34M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $44.39M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $48.55M 10-Q · filed 2017-11-07 |
| 2016-09-30 | $49.61M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $53.30M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $84.39M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $85.39M 10-K · filed 2017-03-23 |
| 2015-09-30 | $100.64M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $96.92M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $105.95M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $58.77M 10-K · filed 2016-03-03 |
| 2014-09-30 | $72.81M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $81.96M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $100.63M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $104.77M 10-K · filed 2015-03-10 |
| 2012-12-31 | $81.42M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |